Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Gene Amplification"" wg kryterium: Temat


Tytuł:
Optimal combination of MYCN differential gene and cellular senescence gene predicts adverse outcomes in patients with neuroblastoma.
Autorzy:
Tan J; Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Wang C; Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Jin Y; Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Department of Pediatric Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Xia Y; Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Gong B; Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Zhao Q; Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Department of Pediatric Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Nov 16; Vol. 14, pp. 1309138. Date of Electronic Publication: 2023 Nov 16 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Gene Amplification*
Neuroblastoma*/pathology
Child ; Humans ; N-Myc Proto-Oncogene Protein/genetics ; N-Myc Proto-Oncogene Protein/metabolism ; Genes, myc ; Cellular Senescence/genetics ; Tumor Microenvironment/genetics ; Membrane Proteins/metabolism ; Intracellular Signaling Peptides and Proteins/metabolism
Czasopismo naukowe
Tytuł:
Stimuli-responsive probes for amplification-based imaging of miRNAs in living cells.
Autorzy:
Wei R; College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Institute of Molecular and Nano Science, Shandong Normal University, Jinan, 250014, PR China.
Wang K; College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Institute of Molecular and Nano Science, Shandong Normal University, Jinan, 250014, PR China.
Liu X; College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Institute of Molecular and Nano Science, Shandong Normal University, Jinan, 250014, PR China.
Shi M; College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Institute of Molecular and Nano Science, Shandong Normal University, Jinan, 250014, PR China.
Pan W; College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Institute of Molecular and Nano Science, Shandong Normal University, Jinan, 250014, PR China. Electronic address: .
Li N; College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Institute of Molecular and Nano Science, Shandong Normal University, Jinan, 250014, PR China. Electronic address: .
Tang B; College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Institute of Molecular and Nano Science, Shandong Normal University, Jinan, 250014, PR China; Laoshan Laboratory, Qingdao, 266237, PR China. Electronic address: .
Pokaż więcej
Źródło:
Biosensors & bioelectronics [Biosens Bioelectron] 2023 Nov 01; Vol. 239, pp. 115584. Date of Electronic Publication: 2023 Aug 09.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Gene Amplification*
Humans ; MicroRNAs/chemistry ; MicroRNAs/genetics ; MicroRNAs/metabolism ; Cell Survival ; Adenosine Triphosphate/metabolism ; Hydrogen-Ion Concentration
Czasopismo naukowe
Tytuł:
Gene amplifications and extrachromosomal circular DNAs: function and biogenesis.
Autorzy:
Yüksel A; Department of Medical Biology and Genetics, Institute of Health Sciences, Dokuz Eylul University, 35330, Izmir, Turkey. .
Altungöz O; Department of Medical Biology and Genetics, Institute of Health Sciences, Dokuz Eylul University, 35330, Izmir, Turkey. .; Department of Medical Biology, Dokuz Eylül Medical School, 35330, Izmir, Turkey. .
Pokaż więcej
Źródło:
Molecular biology reports [Mol Biol Rep] 2023 Sep; Vol. 50 (9), pp. 7693-7703. Date of Electronic Publication: 2023 Jul 11.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Gene Amplification*
DNA, Circular*/genetics
DNA ; Chromosomes ; Oncogenes
Czasopismo naukowe
Tytuł:
Gene amplifications cause high-level resistance against albicidin in gram-negative bacteria.
Autorzy:
Saathoff M; Institute of Microbiology and Epizootics, Freie Universität Berlin, Berlin, Germany.
Kosol S; Institut für Chemie, Technische Universität Berlin, Berlin, Germany.
Semmler T; Robert Koch-Institute (RKI), MF2-Genome Sequencing and Genomic Epidemiology, Berlin, Germany.
Tedin K; Institute of Microbiology and Epizootics, Freie Universität Berlin, Berlin, Germany.
Dimos N; Institute for Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany.
Kupke J; Institute of Microbiology and Epizootics, Freie Universität Berlin, Berlin, Germany.
Seidel M; Institut für Chemie, Technische Universität Berlin, Berlin, Germany.
Ghazisaeedi F; Institute of Microbiology and Epizootics, Freie Universität Berlin, Berlin, Germany.
Jonske MC; Institute of Microbiology and Epizootics, Freie Universität Berlin, Berlin, Germany.
Wolf SA; Robert Koch-Institute (RKI), MF2-Genome Sequencing and Genomic Epidemiology, Berlin, Germany.
Kuropka B; Institute for Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany.
Czyszczoń W; Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.
Ghilarov D; Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.
Grätz S; Institut für Chemie, Technische Universität Berlin, Berlin, Germany.
Heddle JG; Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.
Loll B; Institute for Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany.
Süssmuth RD; Institut für Chemie, Technische Universität Berlin, Berlin, Germany.
Fulde M; Institute of Microbiology and Epizootics, Freie Universität Berlin, Berlin, Germany.; Veterinary Centre for Resistance Research (TZR), Freie Universität Berlin, Berlin, Germany.
Pokaż więcej
Źródło:
PLoS biology [PLoS Biol] 2023 Aug 10; Vol. 21 (8), pp. e3002186. Date of Electronic Publication: 2023 Aug 10 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Amplification*
Anti-Bacterial Agents*/pharmacology
Molecular Docking Simulation ; Phylogeny ; Gram-Negative Bacteria/genetics ; Gram-Positive Bacteria/metabolism
Czasopismo naukowe
Tytuł:
ERα-associated translocations underlie oncogene amplifications in breast cancer.
Autorzy:
Lee JJ; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA. .; Ludwig Center at Harvard, Harvard Medical School, Boston, MA, USA. .; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. .
Jung YL; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.; Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA.
Cheong TC; Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.
Espejo Valle-Inclan J; European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, UK.
Chu C; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
Gulhan DC; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.; Ludwig Center at Harvard, Harvard Medical School, Boston, MA, USA.
Ljungström V; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
Jin H; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
Viswanadham VV; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
Watson EV; Department of Genetics, Harvard Medical School, Boston, MA, USA.; Department of Systems Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA.; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Cortés-Ciriano I; European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, UK.
Elledge SJ; Ludwig Center at Harvard, Harvard Medical School, Boston, MA, USA.; Department of Genetics, Harvard Medical School, Boston, MA, USA.; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Howard Hughes Medical Institute, Chevy Chase, MD, USA.
Chiarle R; Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
Pellman D; Ludwig Center at Harvard, Harvard Medical School, Boston, MA, USA.; Howard Hughes Medical Institute, Chevy Chase, MD, USA.; Department of Cell Biology, Harvard Medical School, Boston, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Park PJ; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA. peter_.; Ludwig Center at Harvard, Harvard Medical School, Boston, MA, USA. peter_.
Pokaż więcej
Źródło:
Nature [Nature] 2023 Jun; Vol. 618 (7967), pp. 1024-1032. Date of Electronic Publication: 2023 May 17.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/genetics
Estrogen Receptor alpha*/metabolism
Gene Amplification*
Oncogenes*/genetics
Translocation, Genetic*/genetics
Female ; Humans ; Estrogens/metabolism ; Genome, Human/genetics ; DNA Breaks, Double-Stranded ; Organ Specificity
Czasopismo naukowe
Tytuł:
Superficial GLI1-amplified mesenchymal neoplasms: Expanding the spectrum of an emerging entity which reaches the realm of dermatopathology.
Autorzy:
Machado I; Pathology Department, Instituto Valenciano de Oncología, Valencia, Spain.; Pathology Department, Patologika Laboratory, Hospital QuironSalud, Valencia, Spain.
Hosler GA; Dermatopathology, ProPath, Dallas, Texas, USA.; Department of Dermatology, University of Texas Southwestern, Dallas, Texas, USA.
Traves V; Pathology Department, Instituto Valenciano de Oncología, Valencia, Spain.
Claramunt R; Laboratory of Molecular Biology, Instituto Valenciano de Oncología, Valencia, Spain.
Sanmartín O; Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain.
Santonja C; Pathology Department, Fundación Jiménez Díaz, Madrid, Spain.
Carvajal N; Pathology Department, Fundación Jiménez Díaz, Madrid, Spain.
Zazo S; Pathology Department, Fundación Jiménez Díaz, Madrid, Spain.
Requena L; Dermatology Department, Fundación Jiménez Díaz, Madrid, Spain.
Alfonso VS; Orthopaedic Department, Hospital Arnau de Vilanova, Valencia, Spain.
Domenech EV; Plastic Surgery Service, University Hospital Castellon, Castellon, Spain.
Llombart-Bosch A; Pathology Department, University of Valencia, Valencia, Spain.
Bridge JA; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA.; Division of Molecular Pathology, ProPath, Dallas, Texas, USA.
Linos K; Department of Pathology & Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Pokaż więcej
Źródło:
Journal of cutaneous pathology [J Cutan Pathol] 2023 Jun; Vol. 50 (6), pp. 487-499. Date of Electronic Publication: 2022 Nov 23.
Typ publikacji:
Case Reports
MeSH Terms:
Zinc Finger Protein GLI1*/genetics
Gene Amplification*
Mesenchymoma*/genetics
Mesenchymoma*/pathology
Skin Neoplasms*/genetics
Skin Neoplasms*/pathology
Glomus Tumor*/genetics
Glomus Tumor*/pathology
Humans ; Male ; Female ; Adult ; Aged ; Mitosis ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/pathology
SCR Disease Name:
Malignant mesenchymal tumor
Raport
Tytuł:
Combined PIK3CA and SOX2 Gene Amplification Predicts Laryngeal Cancer Risk beyond Histopathological Grading.
Autorzy:
Montoro-Jiménez I; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias (IUOPA), University of Oviedo, 33011 Oviedo, Spain.; CIBERONC, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Granda-Díaz R; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias (IUOPA), University of Oviedo, 33011 Oviedo, Spain.; CIBERONC, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Menéndez ST; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias (IUOPA), University of Oviedo, 33011 Oviedo, Spain.; CIBERONC, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Prieto-Fernández L; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias (IUOPA), University of Oviedo, 33011 Oviedo, Spain.; CIBERONC, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Otero-Rosales M; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias (IUOPA), University of Oviedo, 33011 Oviedo, Spain.; CIBERONC, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Álvarez-González M; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias (IUOPA), University of Oviedo, 33011 Oviedo, Spain.
García-de-la-Fuente V; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias (IUOPA), University of Oviedo, 33011 Oviedo, Spain.
Rodríguez A; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias (IUOPA), University of Oviedo, 33011 Oviedo, Spain.
Rodrigo JP; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias (IUOPA), University of Oviedo, 33011 Oviedo, Spain.; CIBERONC, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Álvarez-Teijeiro S; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias (IUOPA), University of Oviedo, 33011 Oviedo, Spain.; CIBERONC, Instituto de Salud Carlos III, 28029 Madrid, Spain.
García-Pedrero JM; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias (IUOPA), University of Oviedo, 33011 Oviedo, Spain.; CIBERONC, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Hermida-Prado F; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias (IUOPA), University of Oviedo, 33011 Oviedo, Spain.; CIBERONC, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 26; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 26.
Typ publikacji:
Journal Article
MeSH Terms:
Laryngeal Neoplasms*/genetics
Precancerous Conditions*/genetics
Humans ; Gene Amplification ; Class I Phosphatidylinositol 3-Kinases/genetics ; Carcinogenesis/genetics ; SOXB1 Transcription Factors/genetics
Czasopismo naukowe
Tytuł:
Gene amplification in neoplasia: A cytogenetic survey of 80 131 cases.
Autorzy:
Mandahl N; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden.
Mertens F; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden.; Division of Laboratory Medicine, Department of Clinical Genetics and Pathology, University Hospital, Lund, Sweden.
Mitelman F; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden.
Pokaż więcej
Źródło:
Genes, chromosomes & cancer [Genes Chromosomes Cancer] 2024 Jan; Vol. 63 (1), pp. e23214. Date of Electronic Publication: 2023 Dec 05.
Typ publikacji:
Journal Article
MeSH Terms:
Sarcoma*/genetics
Neuroblastoma*/genetics
Bone Neoplasms*/genetics
Humans ; Gene Amplification ; Chromosome Aberrations ; Cytogenetic Analysis
Czasopismo naukowe
Tytuł:
Loop-Mediated Isothermal Amplification of DNA (LAMP) as an Alternative Method for Determining Bacteria in Wound Infections.
Autorzy:
Gieroń, Monika (AUTHOR)
Żarnowiec, Paulina (AUTHOR)
Zegadło, Katarzyna (AUTHOR)
Gmiter, Dawid (AUTHOR)
Czerwonka, Grzegorz (AUTHOR)
Kaca, Wiesław (AUTHOR)
Kręcisz, Beata (AUTHOR)
Pokaż więcej
Źródło:
International Journal of Molecular Sciences. Jan2024, Vol. 25 Issue 1, p411. 16p.
Czasopismo naukowe
Tytuł:
Clinical application of the HM-1000 image processing for HER2 fluorescence in situ hybridization signal quantification in breast cancer.
Autorzy:
Peg V; Pathology Department, Vall d'Hebron University Hospital, Passeo Vall d'Hebron, 119-129, 08035, Barcelona, Spain. .; Autonomous University of Barcelona, Barcelona, Spain. .; Spanish Biomedical Research Centre in Cancer (CIBERONC), Madrid, Spain. .
Moline T; Pathology Department, Vall d'Hebron University Hospital, Passeo Vall d'Hebron, 119-129, 08035, Barcelona, Spain.
Roig M; Pathology Department, Vall d'Hebron University Hospital, Passeo Vall d'Hebron, 119-129, 08035, Barcelona, Spain.
Saruta Y; Sysmex R&D Center Europe GmbH, Hamburg, Germany.
Cajal SRY; Pathology Department, Vall d'Hebron University Hospital, Passeo Vall d'Hebron, 119-129, 08035, Barcelona, Spain.; Autonomous University of Barcelona, Barcelona, Spain.; Spanish Biomedical Research Centre in Cancer (CIBERONC), Madrid, Spain.
Pokaż więcej
Źródło:
Diagnostic pathology [Diagn Pathol] 2024 Feb 15; Vol. 19 (1), pp. 32. Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/diagnosis
Humans ; Female ; In Situ Hybridization, Fluorescence/methods ; Retrospective Studies ; Neoplasm Recurrence, Local/genetics ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/metabolism ; Monosomy ; Gene Amplification
Czasopismo naukowe
Tytuł:
Decreased HER2 expression in endometrial cancer following anti-HER2 therapy.
Autorzy:
Chui MH; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Brown DN; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Da Cruz Paula A; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
da Silva EM; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Momeni-Boroujeni A; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Reis-Filho JS; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Zhang Y; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Makker V; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ellenson LH; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Weigelt B; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Pokaż więcej
Źródło:
The Journal of pathology [J Pathol] 2024 Feb; Vol. 262 (2), pp. 129-136. Date of Electronic Publication: 2023 Nov 27.
Typ publikacji:
Journal Article
MeSH Terms:
Receptor, ErbB-2*/genetics
Receptor, ErbB-2*/metabolism
Endometrial Neoplasms*/drug therapy
Endometrial Neoplasms*/genetics
Endometrial Neoplasms*/pathology
Female ; Humans ; In Situ Hybridization, Fluorescence ; Neoplasm Recurrence, Local/genetics ; Trastuzumab/therapeutic use ; Gene Amplification
Czasopismo naukowe
Tytuł:
Emerging Landscape of Targeted Therapy of Breast Cancers With Low Human Epidermal Growth Factor Receptor 2 Protein Expression.
Autorzy:
Tozbikian G; From the Department of Pathology, The Ohio State University, Wexner Medical Center, Columbus (Tozbikian).
Krishnamurthy S; the Department of Pathology (Krishnamurthy), The University of Texas MD Anderson Cancer Center, Houston.
Bui MM; the Department of Pathology, Moffitt Cancer Center & Research Institute, Tampa, Florida (Bui).
Feldman M; the Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Feldman).
Hicks DG; the Department of Pathology, University of Rochester Medical Center, Rochester, New York (Hicks).
Jaffer S; the Department of Pathology, Mount Sinai Medical Center, New York, New York (Jaffer).
Khoury T; the Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, New York (Khoury).
Wei S; the Department of Pathology, University of Kansas Medical Center; Kansas City (Wei).
Wen H; the Department of Pathology, Memorial Sloan Kettering Cancer Center; New York, New York (Wen).
Pohlmann P; the Department of Breast Medical Oncology (Pohlmann), The University of Texas MD Anderson Cancer Center, Houston.
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2024 Feb 01; Vol. 148 (2), pp. 242-255.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Breast Neoplasms*/drug therapy
Breast Neoplasms*/genetics
Breast Neoplasms*/pathology
Humans ; Female ; In Situ Hybridization, Fluorescence ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/metabolism ; Gene Amplification ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism
Czasopismo naukowe
Tytuł:
Identification of PSMB4 and PSMD4 as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma.
Autorzy:
Garcia JB; Hematology and BMT Unit, 'Azienda Ospedaliero-Universitaria di Parma', Parma.
Storti P; Department of Medicine and Surgery, University of Parma, Parma.
Iannozzi NT; Department of Medicine and Surgery, University of Parma, Parma.
Marchica V; Department of Medicine and Surgery, University of Parma, Parma.
Agnelli L; Istituto Nazionale dei Tumori Foundation, Milan.
Toscani D; Department of Medicine and Surgery, University of Parma, Parma.
Franceschi V; Department of Medical-Veterinary Science, University of Parma, Parma.
Todaro G; Hematology and BMT Unit, 'Azienda Ospedaliero-Universitaria di Parma', Parma.
Sammarelli G; Hematology and BMT Unit, 'Azienda Ospedaliero-Universitaria di Parma', Parma.
Notarfranchi L; Department of Medicine and Surgery, University of Parma, Parma.
Scita M; Hematology and BMT Unit, 'Azienda Ospedaliero-Universitaria di Parma', Parma.
Palma BD; Hematology and BMT Unit, 'Azienda Ospedaliero-Universitaria di Parma', Parma.
Raimondi V; Department of Medicine and Surgery, University of Parma, Parma.
Lungu O; Department of Medicine and Surgery, University of Parma, Parma.
Pruneri G; Istituto Nazionale dei Tumori Foundation, Milan.
Donofrio G; Department of Medical-Veterinary Science, University of Parma, Parma.
Giuliani N; Hematology and BMT Unit, 'Azienda Ospedaliero-Universitaria di Parma', Parma, Italy; Department of Medicine and Surgery, University of Parma, Parma. .
Pokaż więcej
Źródło:
Haematologica [Haematologica] 2024 Feb 01; Vol. 109 (2), pp. 627-631. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Myeloma*/diagnosis
Multiple Myeloma*/genetics
Smoldering Multiple Myeloma*
Humans ; Chromosome Aberrations ; Gene Amplification ; RNA-Binding Proteins/genetics ; Proteasome Endopeptidase Complex/metabolism
Czasopismo naukowe
Tytuł:
Posttreatment complications in pediatric cervical neuroblastoma: A retrospective case series at a tertiary cancer center.
Autorzy:
Lopez J; Department of Pediatric Surgery, Division of Pediatric Head & Neck Surgery, AdventHealth for Children, Orlando, Florida, USA.; Department of Surgery, Memorial Sloan Kettering Cancer Center New York, New York, New York, USA.
Subramanian T; Department of Surgery, Memorial Sloan Kettering Cancer Center New York, New York, New York, USA.
Durell J; Department of Surgery, Memorial Sloan Kettering Cancer Center New York, New York, New York, USA.
Levyn H; Department of Surgery, Memorial Sloan Kettering Cancer Center New York, New York, New York, USA.
Wong R; Department of Surgery, Memorial Sloan Kettering Cancer Center New York, New York, New York, USA.
Shah J; Department of Surgery, Memorial Sloan Kettering Cancer Center New York, New York, New York, USA.
LaQuaglia MP; Department of Surgery, Memorial Sloan Kettering Cancer Center New York, New York, New York, USA.
Gerstle JT; Department of Surgery, Memorial Sloan Kettering Cancer Center New York, New York, New York, USA.
Pokaż więcej
Źródło:
Journal of surgical oncology [J Surg Oncol] 2024 Feb; Vol. 129 (2), pp. 219-223. Date of Electronic Publication: 2023 Oct 18.
Typ publikacji:
Journal Article
MeSH Terms:
Neuroblastoma*/drug therapy
Neuroblastoma*/genetics
Child ; Humans ; Infant ; Child, Preschool ; N-Myc Proto-Oncogene Protein/therapeutic use ; Retrospective Studies ; Survival Analysis ; Neoplasm Staging ; Gene Amplification
Czasopismo naukowe
Tytuł:
Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directions.
Autorzy:
Nasioudis D; Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia, PA, USA. Electronic address: .
Gysler S; Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia, PA, USA.
Latif N; Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia, PA, USA.
Cory L; Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia, PA, USA.
Giuntoli RL 2nd; Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia, PA, USA.
Kim SH; Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia, PA, USA.
Simpkins F; Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia, PA, USA.
Martin L; Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia, PA, USA.
Ko EM; Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia, PA, USA.
Pokaż więcej
Źródło:
Gynecologic oncology [Gynecol Oncol] 2024 Jan; Vol. 180, pp. 1-5. Date of Electronic Publication: 2023 Nov 28.
Typ publikacji:
Journal Article
MeSH Terms:
Genital Neoplasms, Female*/genetics
Uterine Cervical Neoplasms*/genetics
Ovarian Neoplasms*/pathology
Uterine Neoplasms*/genetics
Endometrial Neoplasms*/genetics
Endometrial Neoplasms*/pathology
Carcinoma, Endometrioid*/pathology
Carcinosarcoma*/pathology
Humans ; Female ; Gene Amplification ; Phosphatidylinositol 3-Kinases/metabolism ; Mutation ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/metabolism
Czasopismo naukowe
Tytuł:
MDM2 FISH testing criteria in adipose tissue tumors with mature adipocytic morphology - A resection case-based study.
Autorzy:
Li L; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Yue P; State Key Lab of Molecular Oncology, Laboratory of Cell and Molecular Biology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Du Q; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Zhang H; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. Electronic address: .
Song Y; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. Electronic address: .
Pokaż więcej
Źródło:
Pathology, research and practice [Pathol Res Pract] 2024 Jan; Vol. 253, pp. 155039. Date of Electronic Publication: 2023 Dec 16.
Typ publikacji:
Journal Article
MeSH Terms:
Liposarcoma*/diagnosis
Liposarcoma*/genetics
Liposarcoma*/pathology
Lipoma*/diagnosis
Retroperitoneal Neoplasms*
Humans ; In Situ Hybridization, Fluorescence ; Gene Amplification ; Proto-Oncogene Proteins c-mdm2/genetics ; Proto-Oncogene Proteins c-mdm2/metabolism ; Neoplasm Recurrence, Local/diagnosis ; Biomarkers, Tumor
Czasopismo naukowe
Tytuł:
A novel HMGA2::KITLG fusion in a dedifferentiated liposarcoma with amplification of MDM2 and HMGA2.
Autorzy:
Zhou S; Department of Oncology, Xiangya Hospital, Central South University, Changsha, China.
Zhang C; Suzhou Sano Precision Medicine Ltd, Suzhou, China.
Zhang Z; Department of Geratology, Xiangya Hospital, Central South University, Changsha, China.
Hu Y; Department of Pathology, Xiangya Hospital, Central South University, Changsha, China.; Department of Pathology, School of Basic Medical Science, Central South University, Changsha, China.
Zhao L; Suzhou Sano Precision Medicine Ltd, Suzhou, China.
Hu W; Suzhou Sano Precision Medicine Ltd, Suzhou, China.
Chen S; Suzhou Sano Precision Medicine Ltd, Suzhou, China.
Li B; Department of Oncology, Xiangya Hospital, Central South University, Changsha, China.
Xiao S; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Genes, chromosomes & cancer [Genes Chromosomes Cancer] 2024 Jan; Vol. 63 (1), pp. e23200. Date of Electronic Publication: 2023 Sep 12.
Typ publikacji:
Journal Article
MeSH Terms:
Liposarcoma*/genetics
Liposarcoma*/pathology
Lipoma*/genetics
Lipoma*/pathology
Neoplasms, Connective and Soft Tissue*
Humans ; Animals ; Mice ; Proto-Oncogene Proteins c-mdm2/genetics ; Proto-Oncogene Proteins c-mdm2/metabolism ; Gene Amplification
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies